Qrons Inc.: Qrons Announces Filing Of Provisional Patent App

NEW YORK, NY / ACCESSWIRE / April 12, 2022 / Qrons Inc. (OTCQB:QRON), an innovative biotechnology company dedicated to developing next generation treatments for unmet neuronal diseases, using tissue engineering

Related Keywords

New York , United States , Israel , Ido Merfeld , Kostenloser Wertpapierhandel , Jonah Meer , Polypseudorotaxane Hydrogels , Exchange Commission , Qrons Inc , United States Provisional Patent Application , Therapeutic Polypseudorotaxane Hydrogels , Qron President , New York City , Private Securities Litigation Reform Act , Qrons , Nnounces , Filing , Provisional , Patent , Application , Furtherance , Ns200 , Product , Candidate ,